Details for New Drug Application (NDA): 020478
✉ Email this page to a colleague
NDA 020478 describes ULTANE, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. Additional details are available on the ULTANE profile page.
The generic ingredient in ULTANE is sevoflurane. There are five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
The generic ingredient in ULTANE is sevoflurane. There are five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
Summary for 020478
| Tradename: | ULTANE |
| Applicant: | Abbvie |
| Ingredient: | sevoflurane |
| Patents: | 0 |
Pharmacology for NDA: 020478
| Physiological Effect | General Anesthesia |
Suppliers and Packaging for NDA: 020478
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ULTANE | sevoflurane | LIQUID;INHALATION | 020478 | NDA | AbbVie Inc. | 0074-4456 | 0074-4456-04 | 250 mL in 1 BOTTLE, PLASTIC (0074-4456-04) |
| ULTANE | sevoflurane | LIQUID;INHALATION | 020478 | NDA | AbbVie Inc. | 0074-4456 | 0074-4456-51 | 250 mL in 1 BOTTLE, PLASTIC (0074-4456-51) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | LIQUID;INHALATION | Strength | 100% | ||||
| Approval Date: | Jun 7, 1995 | TE: | AN | RLD: | Yes | ||||
Complete Access Available with Subscription
